The Horizon CHO GS ^-/-  cell line is available immediately for cell line development services performed out of their Oklahoma City based facilities. The new cell line is part of a toolbox approach to CHO Cell Line Development, making the Cytovance offering of multiple cell lines for each molecule unique in the CDMO industry.
 

“We’re excited to add the Horizon CHO GS ^-/-  cell line to our expanding CHO toolbox. The ability to interrogate multiple platform technologies in parallel enables Cytovance’s clients to rapidly find the best protein expression option for their program. Combined with a fully integrated development path, the CHO toolbox approach differentiates Cytovance among CDMOs,” said Jesse McCool, PhD, senior vice president of Research and Development Services at Cytovance Biologics. “We constantly strive to find and apply the best technologies.”